CVS Loses Challenge To Sentry's Revamped Antitrust Suit
Sentry Data Systems Inc. can continue its lawsuit against CVS alleging the pharmacy chain is unlawfully forcing health care providers to use its 340B Drug Pricing Program administrator Wellpartner LLC, a...To view the full article, register now.
Already a subscriber? Click here to view full article